Komjathy Andrew
SEC insider (Form 3/4/5 filer). CIK 0001788465. Chief Commercial Officer at Astria Therapeutics, Inc. (ATXS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 23, 2026. Located in BOSTON, MA.
Companies Komjathy Andrew has filed insider reports for
- Astria Therapeutics, Inc. (ATXS): Officer, Chief Commercial Officer
Komjathy Andrew
CIK: 0001788465
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (75.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATXS
Astria Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirect10 shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionIndirect45 shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionIndirect45 shares- - Mar 21, 2025ATXS
Astria Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
225K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition | 10 | - | $0 | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition | 45 | - | $0 | Indirect |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition | 45 | - | $0 | Indirect |
| Mar 21, 2025 | ATXS Astria Therapeutics, Inc. | Award Stock Option (Right to Buy) | 225,000 | - | - | Direct |
1-4 of 4 transactions